Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
Thomas J PolascikDivision of Urology, Department of Surgery, Duke University Medical Center, Durham, NC, USAAbstract: Bone metastases frequently occur in patients with advanced solid tumors, particularly breast and prostate cancers, and nearly all patients with multiple myeloma have some degree of s...
Main Author: | Thomas J Polascik |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-12-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/bisphosphonates-in-oncology-evidence-for-the-prevention-of-skeletal-ev-a2750 |
Similar Items
-
Clinical Use of Bisphosphonates in Patients with Breast Cancer and Bone Metastases
by: Guei-Fang Wang, et al.
Published: (2004) -
Use of disodium pamidronate bisphosphonate in patients with bone metastases of lung cancer
by: Ranković Boško, et al.
Published: (2002-01-01) -
Utilization of bone densitometry for prediction and administration of bisphosphonates to prevent osteoporosis in patients with prostate cancer without bone metastases receiving antiandrogen therapy
by: Holt A, et al.
Published: (2014-12-01) -
Bisphosphonates: from preclinical evidence to survival data in the oncologic setting
by: Daniele Santini, et al.
Published: (2011-12-01) -
Bisphosphonates: from preclinical evidence to survival data in the oncologic setting
by: Daniele Santini, et al.
Published: (2011-12-01)